Andrew Albert "Al" Kucharchuk
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Albert "Al" Kucharchuk
Andrew Albert "Al" Kucharchuk is recorded as CFO at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed October 2, 2024 that Andrew Albert "Al" Kucharchuk was appointed Chief Financial Officer. Cero Therapeutics Holdings, Inc. reported in an 8-K filed October 2, 2024 that Andrew Albert "Al" Kucharchuk was appointed Chief Financial Officer, effective October 1, 2024.
“Andrew Albert "Al" Kucharchuk has been named Chief Financial Officer and Kristen Pierce, Ph.D., has been appointed Chief Development Officer.”
“On September 30, 2024, the Board appointed Andrew Albert "Al" Kucharchuk as Chief Financial Officer of the Company, effective October 1, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
- Michael Byrnes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.